Literature DB >> 24445122

Effects of C358A polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) on weight loss, adipocytokines levels, and insulin resistance after a high polyunsaturated fat diet in obese patients.

D A de Luis1, O Izaola, R Aller, B de La Fuente, D Pacheco.   

Abstract

BACKGROUND AND AIMS: The C385A polymorphism of FAAH gene (rs324420C>A) has been associated with obesity. We investigate the role of this polymorphism on anthropometric and insulin resistance responses to a high polyunsaturated fat hypocaloric diet.
METHODS: Obese individuals (no.=99) were assessed at baseline and after 3 months of a high polyunsaturated fat hypocaloric diet.
RESULTS: Seventy-one patients (71.7%) had the genotype C385C and 28 (28.3%) patients had the C385A (26 patients, 26.3%) or A358A (2 patients, 2.0%) (A allele carriers group) genotype. In A allele carriers and after dietary intervention, total cholesterol (-16.3 ± 37.4 mg/dl) and LDL-cholesterol (-12.9 ± 6.5 mg/dl) levels decreased. In subjects with C385C genotype, the decreases were significant in total cholesterol (-12.3 ± 27.4 mg/dl), LDL-cholesterol (-7.5 ± 20.5 mg/dl), insulin (-2.2 ± 6.2 mUI/l), and homeostasis model assessment of insulin resistance (HOMA-R) (-0.79 ± 1.15 units) levels. The weight loss was similar in both genotype groups (-4.1 ± 3.8 kg vs -4.2 ± 3.2 kg). Only leptin levels had a significant similar decrease in both genotypes.
CONCLUSION: Subjects with C385C genotype of the FAAH showed an improvement on insulin and HOMA-R levels with a high polyunsaturated fat hypocaloric diet after weight loss during 3 months.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24445122     DOI: 10.1007/BF03346760

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  18 in total

1.  Validation of a kinetic model for the reactions in RIA.

Authors:  Maria J Duart Duart; Consuelo Olivas Arroyo; José Luis Moreno Frígols
Journal:  Clin Chem Lab Med       Date:  2002-11       Impact factor: 3.694

2.  Effects of C358A missense polymorphism of the degrading enzyme fatty acid amide hydrolase on weight loss, adipocytokines, and insulin resistance after 2 hypocaloric diets.

Authors:  Daniel Antonio Deluis; Manuel Gonzalez Sagrado; Rocio Aller; Olatz Izaola; Rosa Conde
Journal:  Metabolism       Date:  2010-01-27       Impact factor: 8.694

Review 3.  The epidemiology of obesity.

Authors:  Dang M Nguyen; Hashem B El-Serag
Journal:  Gastroenterol Clin North Am       Date:  2010-03       Impact factor: 3.806

4.  Omega-3 polyunsaturated fatty acids reduce insulin resistance and triglycerides in obese children and adolescents.

Authors:  Carlos Juárez-López; Miguel Klünder-Klünder; Adrián Madrigal-Azcárate; Samuel Flores-Huerta
Journal:  Pediatr Diabetes       Date:  2013-02-25       Impact factor: 4.866

Review 5.  The fatty acid amide hydrolase (FAAH).

Authors:  N Ueda; R A Puffenbarger; S Yamamoto; D G Deutsch
Journal:  Chem Phys Lipids       Date:  2000-11       Impact factor: 3.329

6.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

7.  Leptin-regulated endocannabinoids are involved in maintaining food intake.

Authors:  V Di Marzo; S K Goparaju; L Wang; J Liu; S Bátkai; Z Járai; F Fezza; G I Miura; R D Palmiter; T Sugiura; G Kunos
Journal:  Nature       Date:  2001-04-12       Impact factor: 49.962

8.  Long-chain n-3 PUFAs reduce adipose tissue and systemic inflammation in severely obese nondiabetic patients: a randomized controlled trial.

Authors:  Bianca K Itariu; Maximilian Zeyda; Eva E Hochbrugger; Angelika Neuhofer; Gerhard Prager; Karin Schindler; Arthur Bohdjalian; Daniel Mascher; Suman Vangala; Michael Schranz; Michael Krebs; Martin G Bischof; Thomas M Stulnig
Journal:  Am J Clin Nutr       Date:  2012-10-03       Impact factor: 7.045

9.  The fatty acid amide hydrolase (FAAH) Pro129Thr polymorphism is not associated with severe obesity in Greek subjects.

Authors:  D Papazoglou; I Panagopoulos; N Papanas; T Gioka; T Papadopoulos; P Papathanasiou; O Kaitozis; K Papatheodorou; E Maltezos
Journal:  Horm Metab Res       Date:  2008-09-25       Impact factor: 2.936

10.  A missense mutation in human fatty acid amide hydrolase associated with problem drug use.

Authors:  Jack C Sipe; Kyle Chiang; Alexandra L Gerber; Ernest Beutler; Benjamin F Cravatt
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-11       Impact factor: 11.205

View more
  5 in total

Review 1.  Cannabimimetic phytochemicals in the diet - an evolutionary link to food selection and metabolic stress adaptation?

Authors:  Jürg Gertsch
Journal:  Br J Pharmacol       Date:  2017-01-16       Impact factor: 8.739

Review 2.  Lipidomic approaches to dissect dysregulated lipid metabolism in kidney disease.

Authors:  Judy Baek; Chenchen He; Farsad Afshinnia; George Michailidis; Subramaniam Pennathur
Journal:  Nat Rev Nephrol       Date:  2021-10-06       Impact factor: 42.439

3.  Relationship of the Reported Intakes of Fat and Fatty Acids to Body Weight in US Adults.

Authors:  Susan K Raatz; Zach Conrad; LuAnn K Johnson; Matthew J Picklo; Lisa Jahns
Journal:  Nutrients       Date:  2017-04-28       Impact factor: 5.717

Review 4.  What Role Does the Endocannabinoid System Play in the Pathogenesis of Obesity?

Authors:  Piotr Schulz; Szymon Hryhorowicz; Anna Maria Rychter; Agnieszka Zawada; Ryszard Słomski; Agnieszka Dobrowolska; Iwona Krela-Kaźmierczak
Journal:  Nutrients       Date:  2021-01-26       Impact factor: 5.717

Review 5.  Potential of Fatty Acid Amide Hydrolase (FAAH), Monoacylglycerol Lipase (MAGL), and Diacylglycerol Lipase (DAGL) Enzymes as Targets for Obesity Treatment: A Narrative Review.

Authors:  Justin Matheson; Xin Ming Matthew Zhou; Zoe Bourgault; Bernard Le Foll
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.